RP
Royalty Pharma Plc
🇺🇸XNAS.RPRXUnited StatesHealthcare
$58.75USDup +0.25 (+0.43%)OpenDelayed6:50 PM
Price$58.75+0.25 (+0.43%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- GB00BMVP7Y09
- CUSIP
- 76028H100
Company
- Employees
- 100
- Headquarters
- New York, United States
- CEO
- Mr. Pablo Legorreta
Market
- Shares outstanding
- 445.3M
- Market cap
- $26.16B
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $25.97B
- EPS LTM
- $1.46
- P/E LTM
- 38.72
- Div yield
- 1.26%
Fundamentals (LTM)
- Revenue
- $2.54B+10.01%up year on year
- Net income
- $815.31M-20.12%down year on year
- Gross margin
- 89.28%+30.05%up year on year
- Free cash flow
- $2.98B+23.7%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.